BioSpecifics Technologies

$88.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BSTC and other stocks, options, and ETFs commission-free!

About BSTC

BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. The listed name for BSTC is BioSpecifics Technologies Corp. Common Stock.

CEO
Joseph Truitt
Employees
7
Headquarters
Lynbrook, New York
Founded
1990
Market Cap
649.59M
Price-Earnings Ratio
37.52
Dividend Yield
Average Volume
108.93K
High Today
$88.50
Low Today
$88.32
Open Price
$88.32
Volume
89.71K
52 Week High
$89.15
52 Week Low
$42.00

Collections

BSTC News

BenzingaNov 18

BioSpecifics Merger Investigation: Halper Sadeh LLP Encourages BioSpecifics Technologies Corp. Shareholders to Contact the Firm – BSTC

NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating BioSpecifics Technologies Corp. (

BSTC Earnings

-$0.05
$0.30
$0.65
$1.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
$0.79 per share

You May Also Like